Arsenic Exposure
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Personal Information On Genetic Susceptibility To Arsenic Toxicity
Research Leaders
6 sponsors active, led by University of Chicago
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Returning Genetic Results on Arsenic Susceptibility
Nutrition, Arsenic and Cognitive Function in Children
Selenium in the Treatment of Arsenic Toxicity and Cancers
Research Network
Common Treatments
- Personal Information On Genetic Susceptibility To Arsenic Toxicity1
- Standard Information On Arsenic Exposure Reduction1
- Sodium Selenite1
- Vitamin B121
- Folic Acid1
Active Sponsors
- University of Chicago1
- American Cancer Society, Inc.1
- National Cancer Institute (NCI)1
- Texas Tech University1
- National Institute of Environmental Health Sciences (NIEHS)1
Top Investigators
Columbia University
Texas Tech University
Pritzker School of Medicine, The University of Chicago
Institute of Child & Mother Health, Dhaka, Bangladesh
Related Conditions
- Arsenical Keratosis1
- Arsenical Cancers1
- Arsenic Toxicity1
- Arsenicosis1
- Arsenic Poisoning1